Charles E Ananian, DPM
Podiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 24 years
- California School of Podiatric Medicine, 2002
Offices
2 locations · Gabriel J Halperin D P M Inc · White Memorial Medical Center
Hospitals listed: Adventist Health White Memorial · Pih Health Hospital-Whittier · Providence St Mary Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ananian’s office at (323) 264-6157 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health White MemorialLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.165, Oct 2024 – Sep 2025
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
- Providence St Mary Medical CenterApple Valley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 1 of 5 · 53% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.244, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health White Memorial
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.29) · 473 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.58 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.08 (101.25 to 214.92) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 163 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.8 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.1 · 2,433 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,215 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,320 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.84 (0.46 to 5.23) · 632 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.58) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.96 (2.37 to 19.55) · 186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.48 to 9.73) · 166 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.45 (0 to 1.22) · 2,746 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 207 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.403 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.034 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.673 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.803 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.392 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 257 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 517 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -34.6 · 74 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -21.5 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4 · 208 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 497 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 218 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9 to 16.4) · 199 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 51 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,008 patients answered, 10% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Providence St Mary Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.244 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.93) · 557 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.67 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.35 (90.23 to 208.46) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.9 · 133 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 267 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 292 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,665 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,834 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.24 to 5.95) · 586 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (0.39 to 3.6) · 604 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.7 (0.65 to 18.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (0.72 to 9.16) · 104 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 132 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.12 to 1.58) · 3,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.8 · 30 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.395 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.592 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.479 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 337 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 688 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 27.4 · 115 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.5 · 294 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63 · 278 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 662 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 147 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.5) · 37 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 103 cases | No different | Jan 2024 – Dec 2024 |
What patients said (479 patients answered, 13% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 68% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 60% |
| Doctors "always" listened carefully | 63% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 52% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 63% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 53% |
| Staff "always" explained possible side effects | 34% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$470,729
Medicare paid this office $470,729 for 409 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 254 | $110,861 | $112 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 45 | $51,306 | $206 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 66 | $43,607 | $126 |
| Return visit (30+ min) | 72 | $39,445 | $80 |
| Short return visit (20+ min) | 100 | $34,854 | $54 |
See all 24 services
| Return visit (30+ min) | 254 | $110,861 | $112 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 45 | $51,306 | $206 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 66 | $43,607 | $126 |
| Return visit (30+ min) | 72 | $39,445 | $80 |
| Short return visit (20+ min) | 100 | $34,854 | $54 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 74 | $28,303 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 193 | $21,039 | $40 |
| Removal of skin and tissue, 20.0 sq cm or less | 66 | $18,144 | $48 |
| Short return visit (20+ min) | 64 | $11,279 | $80 |
| Management of oxygen chamber therapy | 25 | $9,090 | $87 |
| Strapping, unna boot | 14 | $6,975 | $51 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 23 | $6,466 | $75 |
| New patient visit (45+ min) | 42 | $5,805 | $138 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, more than 2.0 cm | 23 | $4,615 | $110 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 24 | $3,142 | $79 |
| Long return visit (40+ min) | 15 | $3,008 | $120 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 12 | $2,609 | $93 |
| New patient visit (30+ min) | 34 | $2,265 | $67 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $2,062 | $115 |
| New patient visit (45+ min) | 17 | $1,873 | $110 |
| X-ray of foot, minimum of 3 views | 28 | $1,352 | $31 |
| Short return visit | 16 | $755 | $29 |
| Strapping, unna boot | 11 | $617 | $17 |
| Removal of fingernails or toenails, 6 or more nails | 12 | $371 | $20 |
Procedures Medicare counted
| Removal of nail tissue | 707 | More than 88% of doctors who do this |
| Removal of tissue | 1213 | More than 99% of doctors who do this |
| Removal or shaving of skin growth | 368 | More than 94% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of skin and tissue, 20.0 sq cm or less | 742 | 681 | 759 | 447 | 172 | 396 |
| Removal of fingernails or toenails, 6 or more nails | 100 | 350 | 367 | 343 | 344 | 547 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 230 | 252 | 216 | 152 | 227 | 594 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 211 | 262 | 139 | 51 | 53 | 86 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | – | – | 28 | 28 | 117 | 344 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 164 | 102 | 218 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
409 Original Medicare patients in 2024. Average age 71 · Under 65 24% · 85 and older 13% · Women 51% · Also on Medicaid 81% · Health risk score 3.19. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 52% · Coronary heart disease 40% · Heart failure 40% · Depression 28% · COPD 22% · Atrial fibrillation 17% · Dementia 11% · Stroke 11% · Cancer 7%.
The office billed $1,122,814, Medicare allowed $590,593 and paid $470,729; for 5,277 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 409 | 5,277 | 71 | 3.19 | $1,122,814 | $470,729 |
| 2023 | 293 | 2,995 | 71 | 3.52 | $700,250 | $284,683 |
| 2022 | 313 | 4,746 | 71 | 3.45 | $1,952,319 | $799,443 |
| 2021 | 373 | 4,668 | 70 | 3.62 | $803,644 | $312,089 |
| 2020 | 380 | 4,802 | 70 | 3.73 | $961,815 | $351,955 |
| 2019 | 416 | 5,018 | 70 | 4.07 | $833,018 | $291,129 |
| 2018 | 507 | 5,338 | 70 | 4.08 | $1,038,318 | $360,659 |
| 2017 | 580 | 4,663 | 71 | 4.23 | $798,207 | $281,669 |
| 2016 | 599 | 4,346 | 71 | 3.52 | $752,841 | $269,756 |
| 2015 | 633 | 4,075 | 71 | 3.77 | $647,552 | $247,754 |
| 2014 | 775 | 5,319 | 72 | 3.35 | $703,427 | $271,783 |
| 2013 | 800 | 5,266 | 73 | 3.01 | $744,678 | $273,282 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 151 | $70,764 | $111 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 20 | $42,356 | $206 |
| Short return visit (20+ min) | 56 | $17,168 | $55 |
| Removal of fingernails or toenails, 6 or more nails | 137 | $13,525 | $39 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 48 | $10,130 | $87 |
| Management of oxygen chamber therapy | 12 | $6,197 | $87 |
| Removal of skin and tissue, 20.0 sq cm or less | 37 | $6,042 | $46 |
| Short return visit (20+ min) | 32 | $5,793 | $77 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 28 | $4,756 | $73 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $4,537 | $113 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 17 | $4,468 | $102 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, more than 2.0 cm | 16 | $4,145 | $104 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 14 | $3,856 | $73 |
| Return visit (30+ min) | 25 | $3,826 | $81 |
| New patient visit (45+ min) | 23 | $3,333 | $145 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 12 | $2,685 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,316 | $110 |
| New patient visit (30+ min) | 20 | $1,388 | $69 |
| X-ray of foot, minimum of 3 views | 16 | $653 | $30 |
2022: 20 services
| Return visit (30+ min) | 102 | $44,883 | $112 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 27 | $25,867 | $212 |
| Short return visit (20+ min) | 108 | $19,869 | $79 |
| Short return visit (20+ min) | 77 | $17,555 | $56 |
| Removal of skin and tissue, 20.0 sq cm or less | 52 | $15,192 | $48 |
| Removal of skin and tissue, 20.0 sq cm or less | 23 | $15,065 | $117 |
| Return visit (30+ min) | 38 | $14,367 | $78 |
| Removal of fingernails or toenails, 6 or more nails | 121 | $13,619 | $40 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 45 | $11,107 | $82 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 14 | $3,990 | $78 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 13 | $3,943 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,748 | $172 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 17 | $2,730 | $97 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 11 | $2,301 | $110 |
| New patient visit (30+ min) | 31 | $2,151 | $69 |
| New patient visit (45+ min) | 12 | $1,381 | $115 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $1,113 | $7 |
| X-ray of foot, minimum of 3 views | 17 | $820 | $33 |
| Injection of drug or substance under skin or into muscle | 11 | $651 | $13 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 11 | $67 | None |
2021: 26 services
| Short return visit (20+ min) | 172 | $43,646 | $80 |
| Removal of skin and tissue, 20.0 sq cm or less | 69 | $27,740 | $49 |
| Removal of skin and tissue, 20.0 sq cm or less | 42 | $23,650 | $119 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 35 | $19,748 | $132 |
| Short return visit (20+ min) | 83 | $19,066 | $57 |
| Return visit (30+ min) | 41 | $18,750 | $83 |
| Return visit (30+ min) | 73 | $14,320 | $114 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 26 | $13,982 | $212 |
| Removal of fingernails or toenails, 6 or more nails | 147 | $13,888 | $40 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 28 | $10,359 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,765 | $171 |
| Management of oxygen chamber therapy | 18 | $9,364 | $92 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 34 | $5,794 | $85 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 15 | $5,431 | $69 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 21 | $4,858 | $22 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $3,514 | $47 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | 16 | $2,616 | $93 |
| New patient visit (30+ min) | 17 | $1,692 | $100 |
| New patient visit (30+ min) | 18 | $1,265 | $70 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $1,255 | $66 |
| Removal of tissue from wound, 20.0 sq cm or less | 18 | $1,076 | $31 |
| Injection of drug or substance under skin or into muscle | 11 | $1,055 | $13 |
| X-ray of foot, minimum of 3 views | 19 | $717 | $30 |
| Short return visit | 21 | $672 | $28 |
| Removal of fingernails or toenails, 6 or more nails | 15 | $369 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 11 | $144 | None |
2020: 21 services
| Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter | 20 | $74,430 | $110 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 36 | $34,729 | $209 |
| Short return visit (20+ min) | 156 | $31,256 | $62 |
| Removal of skin and tissue, 20.0 sq cm or less | 95 | $30,514 | $51 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 42 | $21,161 | $81 |
| Short return visit (20+ min) | 118 | $20,508 | $44 |
| Removal of fingernails or toenails, 6 or more nails | 145 | $13,757 | $39 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 26 | $11,737 | $136 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 27 | $11,463 | $72 |
| Removal of skin and tissue, 20.0 sq cm or less | 23 | $9,424 | $115 |
| Management of oxygen chamber therapy | 15 | $9,093 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,909 | $178 |
| Removal of noncancer thickened skin growth, 2-4 growths | 39 | $3,652 | $61 |
| Removal of skin of fingernail or toenail | 11 | $3,161 | $132 |
| Removal of noncancer thickened skin growth, 1 growth | 36 | $3,158 | $52 |
| Removal of tissue from wound, 20.0 sq cm or less | 45 | $2,673 | $32 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 16 | $2,322 | $23 |
| New patient visit (30+ min) | 17 | $1,584 | $93 |
| New patient visit (30+ min) | 24 | $1,576 | $66 |
| Short return visit | 13 | $332 | $22 |
| X-ray of foot, 2 views | 13 | $180 | $9 |
2019: 25 services
| Removal of skin and tissue, 20.0 sq cm or less | 102 | $30,484 | $50 |
| Short return visit (20+ min) | 156 | $28,092 | $63 |
| Short return visit (20+ min) | 127 | $18,372 | $42 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 35 | $18,303 | $131 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 24 | $18,248 | $203 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 33 | $16,596 | $79 |
| Removal of skin and tissue, 20.0 sq cm or less | 34 | $14,810 | $109 |
| Removal of fingernails or toenails, 1-5 nails | 153 | $10,539 | $29 |
| Management of oxygen chamber therapy | 23 | $8,693 | $91 |
| Trimming of dystrophic nails, any number | 152 | $6,505 | $18 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 19 | $6,086 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,318 | $172 |
| Removal of noncancer thickened skin growth, 2-4 growths | 39 | $5,080 | $56 |
| Removal of noncancer thickened skin growth, 1 growth | 42 | $4,656 | $47 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 22 | $3,537 | $22 |
| Removal of fingernails or toenails, 6 or more nails | 79 | $3,432 | $40 |
| New patient visit (30+ min) | 35 | $2,218 | $63 |
| New patient visit (30+ min) | 20 | $1,792 | $90 |
| Short return visit | 29 | $1,677 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,146 | $88 |
| Short return visit | 26 | $636 | $21 |
| Removal of tissue from wound, 20.0 sq cm or less | 21 | $521 | $20 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $351 | $14 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $312 | $21 |
| Removal of fingernails or toenails, 1-5 nails | 11 | $158 | $12 |
2018: 22 services
| Removal of skin and tissue, 20.0 sq cm or less | 106 | $33,498 | $50 |
| Short return visit (20+ min) | 192 | $27,782 | $63 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 46 | $24,716 | $79 |
| Short return visit (20+ min) | 138 | $21,109 | $42 |
| Management of oxygen chamber therapy | 29 | $19,238 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 39 | $17,793 | $106 |
| Removal of fingernails or toenails, 1-5 nails | 167 | $13,694 | $30 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 27 | $13,090 | $71 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 40 | $12,053 | $128 |
| Trimming of dystrophic nails, any number | 164 | $8,688 | $19 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 17 | $8,474 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $6,036 | $172 |
| New patient visit (30+ min) | 66 | $4,127 | $63 |
| Removal of noncancer thickened skin growth, 2-4 growths | 41 | $3,935 | $51 |
| Removal of noncancer thickened skin growth, 1 growth | 44 | $3,361 | $42 |
| New patient visit (30+ min) | 31 | $2,915 | $94 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 15 | $2,620 | $21 |
| Short return visit | 43 | $2,449 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,129 | $89 |
| Removal of tissue from wound, 20.0 sq cm or less | 26 | $825 | $20 |
| Short return visit | 19 | $528 | $21 |
| Removal of fingernails or toenails, 6 or more nails | 16 | $335 | $21 |
2017: 22 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 76 | $34,137 | $131 |
| Short return visit (20+ min) | 203 | $29,920 | $63 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 58 | $29,635 | $80 |
| Removal of skin and tissue, 20.0 sq cm or less | 53 | $23,154 | $104 |
| Short return visit (20+ min) | 135 | $20,872 | $42 |
| Removal of skin and tissue, 20.0 sq cm or less | 104 | $17,988 | $51 |
| Removal of fingernails or toenails, 1-5 nails | 222 | $16,575 | $28 |
| Management of oxygen chamber therapy | 37 | $13,282 | $92 |
| Trimming of dystrophic nails, any number | 221 | $10,321 | $18 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 28 | $10,209 | $71 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 17 | $7,194 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $5,412 | $89 |
| Removal of noncancer thickened skin growth, 1 growth | 78 | $5,325 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 52 | $4,780 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,478 | $172 |
| New patient visit (30+ min) | 66 | $4,175 | $63 |
| Short return visit | 53 | $3,349 | $38 |
| New patient visit (30+ min) | 30 | $2,817 | $94 |
| Removal of bone, 20.0 sq cm or less | 11 | $2,769 | $198 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $2,702 | $47 |
| Removal of fingernails or toenails, 6 or more nails | 20 | $419 | $21 |
| Short return visit | 11 | $250 | $21 |
2016: 24 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 85 | $47,363 | $131 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 66 | $35,612 | $79 |
| Short return visit (20+ min) | 214 | $21,577 | $62 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 29 | $20,536 | $199 |
| Removal of fingernails or toenails, 1-5 nails | 256 | $16,708 | $28 |
| Short return visit (20+ min) | 85 | $11,860 | $43 |
| Removal of skin and tissue, 20.0 sq cm or less | 32 | $10,802 | $103 |
| Removal of skin and tissue, 20.0 sq cm or less | 64 | $10,780 | $46 |
| Management of oxygen chamber therapy | 19 | $9,635 | $91 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 19 | $7,455 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,696 | $172 |
| Short return visit | 106 | $5,913 | $37 |
| Removal of noncancer thickened skin growth, 2-4 growths | 75 | $5,887 | $49 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 19 | $5,244 | $46 |
| Trimming of dystrophic nails, any number | 178 | $4,742 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $4,405 | $88 |
| New patient visit (30+ min) | 47 | $4,363 | $93 |
| Removal of noncancer thickened skin growth, 1 growth | 73 | $4,176 | $41 |
| Removal of fingernails or toenails, 6 or more nails | 58 | $3,225 | $39 |
| New patient visit (30+ min) | 50 | $3,158 | $63 |
| Removal of bone, 20.0 sq cm or less | 12 | $3,147 | $197 |
| Trimming of fingernails or toenails | 182 | $3,110 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $264 | $18 |
| Removal of fingernails or toenails, 6 or more nails | 12 | $253 | $21 |
2015: 24 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 46 | $40,911 | $198 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 51 | $28,252 | $132 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 38 | $25,827 | $82 |
| Removal of fingernails or toenails, 1-5 nails | 227 | $14,566 | $28 |
| Short return visit | 157 | $12,018 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $11,735 | $88 |
| Short return visit (20+ min) | 109 | $11,049 | $62 |
| Removal of skin and tissue, 20.0 sq cm or less | 31 | $9,782 | $101 |
| Short return visit (20+ min) | 56 | $8,989 | $43 |
| Removal of skin and tissue, 20.0 sq cm or less | 43 | $8,832 | $51 |
| Removal of noncancer thickened skin growth, 2-4 growths | 92 | $8,393 | $51 |
| Trimming of fingernails or toenails | 234 | $5,794 | $10 |
| Removal of fingernails or toenails, 6 or more nails | 101 | $5,450 | $38 |
| Removal of noncancer thickened skin growth, 1 growth | 75 | $4,596 | $42 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $4,471 | $47 |
| New patient visit (30+ min) | 30 | $2,574 | $86 |
| New patient visit (30+ min) | 36 | $2,272 | $63 |
| Injection into tendon or ligament | 21 | $2,077 | $45 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 61 | $2,022 | $17 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,883 | $171 |
| Removal of noncancer thickened skin growth, more than 4 growths | 11 | $747 | $57 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 12 | $717 | $55 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $400 | $20 |
| Removal of fingernails or toenails, 6 or more nails | 17 | $371 | $21 |
2014: 24 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 50 | $37,554 | $198 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 49 | $35,359 | $132 |
| Removal of fingernails or toenails, 1-5 nails | 359 | $24,899 | $28 |
| Short return visit (20+ min) | 196 | $19,947 | $62 |
| Short return visit | 214 | $14,963 | $38 |
| Removal of skin and tissue, 20.0 sq cm or less | 43 | $13,586 | $101 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 26 | $12,874 | $84 |
| Short return visit (20+ min) | 57 | $11,157 | $43 |
| Trimming of fingernails or toenails | 358 | $9,314 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $8,781 | $87 |
| Removal of fingernails or toenails, 6 or more nails | 133 | $8,223 | $38 |
| Removal of noncancer thickened skin growth, 2-4 growths | 101 | $7,863 | $50 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 243 | $7,015 | $17 |
| Removal of noncancer thickened skin growth, 1 growth | 86 | $5,509 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 25 | $4,767 | $52 |
| Removal of tissue from wound, 20.0 sq cm or less | 29 | $4,334 | $68 |
| New patient visit (30+ min) | 41 | $3,780 | $92 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 12 | $3,436 | $62 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $1,922 | $58 |
| Injection into tendon or ligament | 15 | $1,863 | $49 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 20 | $1,246 | $38 |
| Strapping, unna boot | 15 | $1,194 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $965 | $60 |
| Removal of fingernails or toenails, 6 or more nails | 32 | $732 | $21 |
2013: 29 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 54 | $45,946 | $127 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 55 | $40,000 | $195 |
| Removal of fingernails or toenails, 1-5 nails | 380 | $22,122 | $28 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 28 | $15,312 | $84 |
| Short return visit | 223 | $15,295 | $37 |
| Removal of skin and tissue, 20.0 sq cm or less | 45 | $10,364 | $102 |
| Short return visit (20+ min) | 56 | $8,865 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 289 | $8,518 | $17 |
| Removal of noncancer thickened skin growth, 2-4 growths | 115 | $8,480 | $51 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 13 | $7,848 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $7,840 | $83 |
| Removal of noncancer thickened skin growth, 1 growth | 116 | $7,276 | $42 |
| Removal of skin and tissue, 20.0 sq cm or less | 36 | $6,863 | $51 |
| Removal of fingernails or toenails, 6 or more nails | 121 | $6,697 | $37 |
| Trimming of fingernails or toenails | 377 | $6,514 | $8 |
| Removal of muscle and/or tissue, each additional 20.0 sq cm or less | 15 | $4,327 | $61 |
| Removal of tissue from wound, 20.0 sq cm or less | 28 | $4,141 | $68 |
| New patient visit (30+ min) | 41 | $3,618 | $88 |
| Short return visit (20+ min) | 44 | $3,258 | $60 |
| Injection into tendon or ligament | 26 | $2,146 | $45 |
| Strapping, unna boot | 18 | $1,903 | $42 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $1,634 | $54 |
| X-ray of foot, minimum of 3 views | 25 | $1,396 | $28 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 16 | $1,078 | $36 |
| New patient visit (30+ min) | 18 | $1,046 | $58 |
| New patient visit (15+ min) | 13 | $819 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $744 | $57 |
| Removal of fingernails or toenails, 6 or more nails | 27 | $553 | $20 |
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, each additional 25.0 sq cm of wound 100.0 sq cm or less | 12 | $520 | $21 |
Medicaid work
$145,149 in 2024
Medicaid paid $145,149 for 4,647 billed services this clinician did in 2024, up to 146 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,668 | $40,815 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 522 | $38,959 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 619 | $26,492 |
| Debridement of nail(s) by any method(s); 6 or more | 527 | $11,623 |
| New patient visit (45+ min) | 218 | $10,532 |
| Short return visit (20+ min) | 827 | $8,495 |
| SHAVE SKIN LESION 0.6-1.0 CM | 187 | $6,959 |
| X-RAY EXAM OF FOOT | 58 | $765 |
| SHAVE SKIN LESION 0.5 CM/< | 21 | $509 |
| 2024 | 4,647 | 9 | 146 | $145,149 |
| 2023 | 4,575 | 7 | 87 | $153,094 |
| 2022 | 4,162 | 8 | 93 | $144,626 |
| 2021 | 2,992 | 10 | 82 | $121,856 |
| 2020 | 3,440 | 9 | 108 | $170,207 |
| 2019 | 2,590 | 7 | 110 | $126,565 |
| 2018 | 2,340 | 8 | 147 | $105,770 |
See the largest Medicaid services in earlier years
2023
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 844 | $44,506 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 548 | $42,345 |
| Return visit (30+ min) | 1,292 | $35,895 |
| Short return visit (20+ min) | 1,340 | $15,772 |
| Debridement of nail(s) by any method(s); 6 or more | 398 | $7,769 |
| New patient visit (45+ min) | 106 | $5,696 |
| SHAVE SKIN LESION 0.6-1.0 CM | 47 | $1,112 |
2022
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 1,050 | $54,552 |
| Return visit (30+ min) | 1,162 | $37,618 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 324 | $25,778 |
| Short return visit (20+ min) | 1,023 | $17,361 |
| Debridement of nail(s) by any method(s); 6 or more | 318 | $6,025 |
| SHAVE SKIN LESION 0.5 CM/< | 68 | $1,317 |
| OFF/OP EST MAY X REQ PHY/QHP | 204 | $1,204 |
| New patient visit (30+ min) | 13 | $771 |
2021
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 894 | $48,694 |
| Short return visit (20+ min) | 899 | $25,750 |
| Return visit (30+ min) | 616 | $19,930 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 210 | $18,676 |
| Debridement of nail(s) by any method(s); 6 or more | 272 | $6,346 |
| Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area | 31 | $1,598 |
| New patient visit (30+ min) | 12 | $499 |
| SHAVE SKIN LESION 0.5 CM/< | 18 | $213 |
| Short return visit | 13 | $151 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 27 | $0 |
2020
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 1,325 | $73,948 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 370 | $39,886 |
| Short return visit (20+ min) | 1,199 | $35,059 |
| Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area | 189 | $8,378 |
| Surgical boot/shoe, each | 75 | $5,009 |
| Debridement of nail(s) by any method(s); 6 or more | 182 | $4,363 |
| New patient visit (30+ min) | 35 | $2,159 |
| Return visit (30+ min) | 22 | $712 |
| SHAVE SKIN LESION 0.5 CM/< | 43 | $693 |
2019
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 940 | $65,215 |
| Short return visit (20+ min) | 1,074 | $24,773 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 196 | $20,009 |
| Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area | 171 | $11,173 |
| Debridement of nail(s) by any method(s); 6 or more | 131 | $3,005 |
| HYPERBARIC OXYGEN THERAPY | 38 | $2,320 |
| Trimming of dystrophic nails, any number | 40 | $70 |
2018
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 813 | $51,026 |
| Short return visit (20+ min) | 977 | $19,363 |
| Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less | 214 | $15,517 |
| Clinic visit/encounter, all-inclusive | 54 | $14,556 |
| Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area | 94 | $4,524 |
| New patient visit (30+ min) | 14 | $616 |
| Debridement of nail(s) by any method(s); 1 to 5 | 15 | $125 |
| Trimming of dystrophic nails, any number | 159 | $42 |
Drugs they prescribed that Part D paid
$169,352
Pharmacies billed $169,352 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (128 of 3,498) in 2024. At or below the middle of the specialty; the typical podiatry clinician is at 5%.
2,914 generic and fewer than 11 brand-name prescriptions · $169,352 in drug cost · 709 antibiotic prescriptions to 300 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Santyl | 72 | $60,355 | $838 |
| Regranex | 32 | $39,516 | $1,235 |
| Ketoconazole | 472 | $13,129 | $28 |
| Clotrimazole | 389 | $12,413 | $32 |
| Fluocinonide | 80 | $4,316 | $54 |
See all 30 drugs
| Santyl | 72 | $60,355 | $838 |
| Regranex | 32 | $39,516 | $1,235 |
| Ketoconazole | 472 | $13,129 | $28 |
| Clotrimazole | 389 | $12,413 | $32 |
| Fluocinonide | 80 | $4,316 | $54 |
| Ssd | 342 | $3,888 | $11 |
| Diclofenac | 81 | $3,764 | $46 |
| Ciclopirox | 93 | $2,478 | $27 |
| Ammonium Lactate | 229 | $2,235 | $10 |
| Vancomycin | 12 | $2,085 | $174 |
| Terbinafine | 122 | $1,335 | $11 |
| Silver Sulfadiazine | 93 | $1,260 | $14 |
| Econazole Nitrate | 26 | $1,060 | $41 |
| Amoxicillin-Clavulanate Potass | 151 | $1,032 | $7 |
| Triamcinolone Acetonide | 95 | $891 | $9 |
| Sulfamethoxazole-Trimethoprim | 223 | $691 | $3 |
| Clindamycin | 97 | $618 | $6 |
| Gabapentin | 116 | $567 | $5 |
| Meloxicam | 158 | $459 | $3 |
| Clotrimazole-Betamethasone | 16 | $313 | $20 |
| Mupirocin | 44 | $264 | $6 |
| Cephalexin | 43 | $251 | $6 |
| Doxycycline Hyclate | 43 | $249 | $6 |
| Acetaminophen-Codeine | 49 | $245 | $5 |
| Ciprofloxacin | 48 | $201 | $4 |
| Levofloxacin | 58 | $183 | $3 |
| Ibuprofen | 50 | $183 | $4 |
| Tramadol | 73 | $165 | $2 |
| Sodium Chloride | 28 | $100 | $4 |
| Cyclobenzaprine | 16 | $40 | $2 |
Year by year
| 2024 | 3,498 | 1,139 | 4% (128) | None | $169,352 |
| 2023 | 1,594 | 541 | 5% (78) | 20% | $271,369 |
| 2022 | 1,311 | 495 | 6% (81) | None | $168,332 |
| 2021 | 1,226 | 394 | 8% (102) | 19% | $121,176 |
| 2020 | 1,442 | 371 | 3% (49) | 22% | $244,280 |
| 2019 | 1,197 | 350 | 7% (85) | None | $206,189 |
| 2018 | 1,110 | 353 | 11% (124) | 22% | $102,680 |
| 2017 | 1,397 | 405 | 11% (146) | 25% | $168,356 |
| 2016 | 1,506 | 427 | 10% (149) | 28% | $132,516 |
| 2015 | 1,450 | 386 | 11% (166) | 24% | $128,979 |
| 2014 | 1,673 | 430 | 11% (177) | None | $100,275 |
| 2013 | 1,696 | 444 | 13% (224) | None | $75,759 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Santyl | 104 | $159,616 | $1,535 |
| Regranex | 45 | $61,810 | $1,374 |
| Diclofenac | 49 | $14,398 | $294 |
| Ketoconazole | 148 | $6,682 | $45 |
| Clotrimazole | 92 | $3,724 | $40 |
| Fluocinonide | 32 | $2,367 | $74 |
| Ciclopirox | 53 | $2,192 | $41 |
| Ammonium Lactate | 136 | $2,128 | $16 |
| Silver Sulfadiazine | 73 | $1,380 | $19 |
| Ssd | 73 | $1,272 | $17 |
| Econazole Nitrate | 16 | $1,082 | $68 |
| Gabapentin | 60 | $861 | $14 |
| Clindamycin | 67 | $753 | $11 |
| Sulfamethoxazole-Trimethoprim | 128 | $684 | $5 |
| Amoxicillin-Clavulanate Potass | 50 | $663 | $13 |
| Terbinafine | 23 | $654 | $28 |
| Levofloxacin | 56 | $642 | $11 |
| Doxycycline Hyclate | 37 | $492 | $13 |
| Triamcinolone Acetonide | 41 | $475 | $12 |
| Meloxicam | 43 | $461 | $11 |
| Tramadol | 56 | $301 | $5 |
| Cephalexin | 22 | $197 | $9 |
| Ibuprofen | 20 | $155 | $8 |
| Hydrocodone-Acetaminophen | 12 | $143 | $12 |
| Mupirocin | 14 | $111 | $8 |
| Ciprofloxacin | 21 | $106 | $5 |
| Sodium Chloride | 14 | $63 | $4 |
2022: 27 drugs
| Santyl | 71 | $88,366 | $1,245 |
| Regranex | 33 | $43,524 | $1,319 |
| Ketoconazole | 87 | $5,098 | $59 |
| Clotrimazole | 107 | $4,533 | $42 |
| Econazole Nitrate | 35 | $3,962 | $113 |
| Fluocinonide | 44 | $3,877 | $88 |
| Diclofenac | 35 | $2,630 | $75 |
| Ssd | 86 | $1,630 | $19 |
| Silver Sulfadiazine | 66 | $1,114 | $17 |
| Ciclopirox | 32 | $848 | $26 |
| Ammonium Lactate | 50 | $828 | $17 |
| Amoxicillin-Clavulanate Potass | 52 | $808 | $16 |
| Clindamycin | 65 | $790 | $12 |
| Gabapentin | 50 | $651 | $13 |
| Sulfamethoxazole-Trimethoprim | 83 | $411 | $5 |
| Triamcinolone Acetonide | 38 | $409 | $11 |
| Ibuprofen | 40 | $317 | $8 |
| Doxycycline Hyclate | 15 | $311 | $21 |
| Meloxicam | 58 | $302 | $5 |
| Terbinafine | 25 | $272 | $11 |
| Cephalexin | 26 | $268 | $10 |
| Tramadol | 51 | $183 | $4 |
| Levofloxacin | 26 | $169 | $7 |
| Hydrocodone-Acetaminophen | 15 | $130 | $9 |
| Acetaminophen-Codeine | 15 | $109 | $7 |
| Ciprofloxacin | 21 | $107 | $5 |
| Mupirocin | 11 | $76 | $7 |
2021: 27 drugs
| Santyl | 72 | $68,548 | $952 |
| Econazole Nitrate | 58 | $7,609 | $131 |
| Fluocinonide | 94 | $6,840 | $73 |
| Diclofenac | 32 | $2,596 | $81 |
| Clobetasol Propionate | 11 | $2,539 | $231 |
| Clotrimazole | 56 | $2,522 | $45 |
| Ketoconazole | 50 | $2,439 | $49 |
| Ssd | 87 | $1,367 | $16 |
| Silver Sulfadiazine | 59 | $1,081 | $18 |
| Doxycycline Hyclate | 16 | $985 | $62 |
| Ciclopirox | 32 | $833 | $26 |
| Amoxicillin-Clavulanate Potass | 52 | $623 | $12 |
| Sulfamethoxazole-Trimethoprim | 82 | $595 | $7 |
| Ammonium Lactate | 18 | $389 | $22 |
| Ciprofloxacin | 64 | $379 | $6 |
| Terbinafine | 24 | $361 | $15 |
| Clindamycin | 38 | $360 | $9 |
| Gabapentin | 48 | $354 | $7 |
| Mupirocin | 31 | $285 | $9 |
| Cephalexin | 33 | $214 | $6 |
| Hydrocodone-Acetaminophen | 19 | $208 | $11 |
| Acetaminophen-Codeine | 25 | $195 | $8 |
| Tramadol | 58 | $185 | $3 |
| Triamcinolone Acetonide | 18 | $184 | $10 |
| Levofloxacin | 22 | $155 | $7 |
| Meloxicam | 43 | $137 | $3 |
| Ibuprofen | 20 | $122 | $6 |
2020: 27 drugs
| Santyl | 106 | $110,628 | $1,044 |
| Regranex | 71 | $97,503 | $1,373 |
| Fluocinonide | 128 | $6,483 | $51 |
| Econazole Nitrate | 44 | $4,466 | $101 |
| Diclofenac | 40 | $3,712 | $93 |
| Ketoconazole | 73 | $2,864 | $39 |
| Ciclopirox | 52 | $2,079 | $40 |
| Linezolid | 12 | $1,691 | $141 |
| Ssd | 89 | $1,456 | $16 |
| Mupirocin | 76 | $839 | $11 |
| Clindamycin | 75 | $807 | $11 |
| Clotrimazole | 17 | $770 | $45 |
| Amoxicillin-Clavulanate Potass | 73 | $731 | $10 |
| Sulfamethoxazole-Trimethoprim | 108 | $585 | $5 |
| Ciprofloxacin | 109 | $566 | $5 |
| Doxycycline Hyclate | 26 | $531 | $20 |
| Silver Sulfadiazine | 33 | $524 | $16 |
| Triamcinolone Acetonide | 26 | $301 | $12 |
| Gabapentin | 34 | $267 | $8 |
| Ammonium Lactate | 13 | $232 | $18 |
| Cephalexin | 33 | $206 | $6 |
| Tramadol | 31 | $131 | $4 |
| Ibuprofen | 14 | $126 | $9 |
| Terbinafine | 15 | $108 | $7 |
| Levofloxacin | 17 | $105 | $6 |
| Meloxicam | 23 | $68 | $3 |
| Acetaminophen-Codeine | 13 | $50 | $4 |
2019: 30 drugs
| Regranex | 56 | $71,302 | $1,273 |
| Santyl | 89 | $52,258 | $587 |
| Erythromycin | 16 | $16,094 | $1,006 |
| Diclofenac | 33 | $6,834 | $207 |
| Nystatin | 16 | $5,948 | $372 |
| Triamcinolone Acetonide | 19 | $5,914 | $311 |
| Linezolid | 14 | $4,188 | $299 |
| Fluocinonide | 69 | $3,244 | $47 |
| Econazole Nitrate | 26 | $2,828 | $109 |
| Voltaren | 11 | $2,348 | $213 |
| Ssd | 83 | $1,955 | $24 |
| Ketoconazole | 41 | $1,565 | $38 |
| Ciclopirox | 33 | $965 | $29 |
| Silver Sulfadiazine | 40 | $714 | $18 |
| Mupirocin | 52 | $664 | $13 |
| Ciprofloxacin | 89 | $626 | $7 |
| Clindamycin | 52 | $587 | $11 |
| Gabapentin | 40 | $492 | $12 |
| Tramadol | 58 | $353 | $6 |
| Cephalexin | 41 | $339 | $8 |
| Sulfamethoxazole-Trimethoprim | 65 | $315 | $5 |
| Doxycycline Hyclate | 11 | $268 | $24 |
| Amoxicillin-Clavulanate Potass | 17 | $212 | $12 |
| Levofloxacin | 34 | $166 | $5 |
| Terbinafine | 14 | $114 | $8 |
| Acetaminophen-Codeine | 21 | $87 | $4 |
| Sodium Chloride | 11 | $79 | $7 |
| Ibuprofen | 12 | $68 | $6 |
| Ibu | 13 | $67 | $5 |
| Meloxicam | 22 | $60 | $3 |
2018: 25 drugs
| Santyl | 69 | $29,174 | $423 |
| Regranex | 12 | $14,911 | $1,243 |
| Fluocinonide | 66 | $4,905 | $74 |
| Voltaren | 20 | $4,902 | $245 |
| Linezolid | 12 | $3,949 | $329 |
| Econazole Nitrate | 29 | $3,625 | $125 |
| Ketoconazole | 43 | $2,829 | $66 |
| Diclofenac | 13 | $2,287 | $176 |
| Silver Sulfadiazine | 87 | $1,599 | $18 |
| Levofloxacin | 81 | $823 | $10 |
| Doxycycline Hyclate | 26 | $818 | $31 |
| Ssd | 38 | $784 | $21 |
| Gabapentin | 45 | $764 | $17 |
| Ciclopirox | 24 | $730 | $30 |
| Clotrimazole | 13 | $675 | $52 |
| Clindamycin | 45 | $482 | $11 |
| Tramadol | 60 | $451 | $8 |
| Amoxicillin-Clavulanate Potass | 23 | $441 | $19 |
| Ciprofloxacin | 56 | $426 | $8 |
| Acetaminophen-Codeine | 54 | $296 | $5 |
| Sulfamethoxazole-Trimethoprim | 64 | $288 | $5 |
| Meloxicam | 47 | $251 | $5 |
| Cephalexin | 24 | $233 | $10 |
| Terbinafine | 27 | $226 | $8 |
| Mupirocin | 14 | $217 | $15 |
2017: 22 drugs
| Santyl | 104 | $80,750 | $776 |
| Econazole Nitrate | 68 | $13,238 | $195 |
| Fluocinonide | 145 | $12,312 | $85 |
| Ketoconazole | 59 | $4,614 | $78 |
| Vancomycin | 25 | $2,219 | $89 |
| Silver Sulfadiazine | 109 | $2,089 | $19 |
| Ciclopirox | 39 | $1,113 | $29 |
| Levofloxacin | 105 | $1,083 | $10 |
| Clotrimazole | 20 | $1,007 | $50 |
| Gabapentin | 60 | $740 | $12 |
| Ssd | 39 | $732 | $19 |
| Clindamycin | 70 | $635 | $9 |
| Doxycycline Hyclate | 21 | $446 | $21 |
| Sulfamethoxazole-Trimethoprim | 76 | $442 | $6 |
| Tramadol | 56 | $411 | $7 |
| Hydrocodone-Acetaminophen | 48 | $400 | $8 |
| Amoxicillin-Clavulanate Potass | 31 | $359 | $12 |
| Ciprofloxacin | 53 | $292 | $6 |
| Acetaminophen-Codeine | 42 | $273 | $7 |
| Meloxicam | 42 | $155 | $4 |
| Sodium Chloride | 22 | $149 | $7 |
| Mupirocin | 15 | $142 | $9 |
2016: 27 drugs
| Econazole Nitrate | 142 | $32,622 | $230 |
| Santyl | 78 | $28,727 | $368 |
| Fluocinonide | 157 | $12,660 | $81 |
| Regranex | 11 | $10,674 | $970 |
| Invanz | 12 | $9,933 | $828 |
| Lyrica | 15 | $6,541 | $436 |
| Silver Sulfadiazine | 116 | $2,997 | $26 |
| Ciclopirox | 67 | $1,882 | $28 |
| Levofloxacin | 149 | $1,794 | $12 |
| Vancomycin | 11 | $1,518 | $138 |
| Vancomycin | 11 | $1,108 | $101 |
| Ketoconazole | 13 | $1,059 | $81 |
| Ssd | 45 | $1,026 | $23 |
| Doxycycline Hyclate | 28 | $821 | $29 |
| Clotrimazole | 15 | $704 | $47 |
| Hydrocodone-Acetaminophen | 63 | $699 | $11 |
| Gabapentin | 66 | $603 | $9 |
| Sulfamethoxazole-Trimethoprim | 98 | $449 | $5 |
| Amoxicillin-Clavulanate Potass | 21 | $385 | $18 |
| Clindamycin | 26 | $347 | $13 |
| Ciprofloxacin | 45 | $312 | $7 |
| Acetaminophen-Codeine | 41 | $306 | $7 |
| Tramadol | 45 | $304 | $7 |
| Terbinafine | 29 | $271 | $9 |
| Sodium Chloride | 31 | $185 | $6 |
| Meloxicam | 40 | $144 | $4 |
| Ibuprofen | 11 | $63 | $6 |
2015: 28 drugs
| Econazole Nitrate | 155 | $45,471 | $293 |
| Fluocinonide | 160 | $15,982 | $100 |
| Invanz | 20 | $13,244 | $662 |
| Santyl | 26 | $10,807 | $416 |
| Lyrica | 23 | $7,999 | $348 |
| Voltaren | 31 | $7,135 | $230 |
| Vancomycin | 32 | $3,081 | $96 |
| Silver Sulfadiazine | 106 | $2,824 | $27 |
| Ciclopirox | 79 | $2,598 | $33 |
| Levofloxacin | 152 | $1,552 | $10 |
| Duloxetine | 11 | $1,002 | $91 |
| Hydrocodone-Acetaminophen | 77 | $811 | $11 |
| Ssd | 28 | $769 | $27 |
| Ketoconazole | 13 | $762 | $59 |
| Gabapentin | 72 | $563 | $8 |
| Amoxicillin-Clavulanate Potass | 45 | $530 | $12 |
| Sulfamethoxazole-Trimethoprim | 69 | $406 | $6 |
| Sodium Chloride | 14 | $391 | $28 |
| Tramadol | 50 | $267 | $5 |
| Acetaminophen-Codeine | 39 | $218 | $6 |
| Terbinafine | 19 | $173 | $9 |
| Clindamycin | 17 | $163 | $10 |
| Sodium Chloride | 24 | $137 | $6 |
| Ciprofloxacin | 15 | $128 | $9 |
| Meloxicam | 34 | $128 | $4 |
| Cephalexin | 11 | $114 | $10 |
| Ibuprofen | 12 | $94 | $8 |
| Carvedilol | 11 | $40 | $4 |
2014: 24 drugs
| Econazole Nitrate | 225 | $16,684 | $74 |
| Santyl | 38 | $11,312 | $298 |
| Fluocinonide | 239 | $10,931 | $46 |
| Lyrica | 32 | $8,455 | $264 |
| Voltaren | 36 | $7,344 | $204 |
| Invanz | 12 | $7,191 | $599 |
| Vancomycin | 65 | $5,477 | $84 |
| Duloxetine | 27 | $4,231 | $157 |
| Silver Sulfadiazine | 118 | $3,087 | $26 |
| Ciclopirox | 76 | $3,018 | $40 |
| Piperacillin-Tazobactam | 11 | $2,354 | $214 |
| Levofloxacin | 178 | $1,986 | $11 |
| Gabapentin | 89 | $881 | $10 |
| Amox Tr-Potassium Clavulanate | 45 | $810 | $18 |
| Ssd | 29 | $616 | $21 |
| Hydrocodone-Acetaminophen | 72 | $499 | $7 |
| Tramadol | 50 | $372 | $7 |
| Acetaminophen-Codeine | 55 | $332 | $6 |
| Sulfamethoxazole-Trimethoprim | 50 | $307 | $6 |
| Terbinafine | 25 | $241 | $10 |
| Clindamycin | 14 | $131 | $9 |
| Sodium Chloride | 26 | $127 | $5 |
| Meloxicam | 28 | $120 | $4 |
| Ibuprofen | 11 | $119 | $11 |
2013: 24 drugs
| Cymbalta | 46 | $14,555 | $316 |
| Invanz | 17 | $10,264 | $604 |
| Econazole Nitrate | 207 | $6,795 | $33 |
| Fluocinonide | 220 | $6,311 | $29 |
| Lyrica | 26 | $6,026 | $232 |
| Santyl | 27 | $5,999 | $222 |
| Voltaren | 24 | $4,049 | $169 |
| Levofloxacin | 269 | $3,033 | $11 |
| Silver Sulfadiazine | 107 | $2,976 | $28 |
| Ciclopirox | 65 | $1,882 | $29 |
| Vancomycin | 21 | $1,829 | $87 |
| Ssd | 52 | $1,733 | $33 |
| Gabapentin | 100 | $1,434 | $14 |
| Amox Tr-Potassium Clavulanate | 32 | $790 | $25 |
| Hydrocodone-Acetaminophen | 100 | $604 | $6 |
| Tramadol | 58 | $446 | $8 |
| Acetaminophen-Codeine | 66 | $353 | $5 |
| Sulfamethoxazole-Trimethoprim | 39 | $302 | $8 |
| Meloxicam | 36 | $246 | $7 |
| Terbinafine | 18 | $226 | $13 |
| Clindamycin | 11 | $217 | $20 |
| Sodium Chloride | 28 | $136 | $5 |
| Cephalexin | 14 | $135 | $10 |
| Cyclobenzaprine | 17 | $96 | $6 |
Money from drug and device companies
$1,138 in 2025
| 2025 | 8 | 32 | None | $1,138 |
| 2024 | 7 | 32 | None | $1,492 |
| 2023 | 8 | 45 | $8,800 | $11,915 |
| 2022 | 7 | 44 | $11,220 | $13,969 |
| 2021 | 4 | 61 | None | $2,100 |
| 2020 | 8 | 118 | $4,400 | $6,829 |
| 2019 | 11 | 317 | $23,500 | $31,202 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Grafix Pl | $698 | 21 payments
|
| Medtronic | Inceptiv | $157 | 1 payment
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $125 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $77 | 4 payments
|
| Abbvie | Teflaro | $30 | 2 payments
|
| Organogenesis | Apligraf | $26 | 1 payment
|
See all 32 published payments
| Smith+Nephew | Meals · 2025-12-27 | Grafix Pl | $45 |
| Organogenesis | Meals · 2025-12-23 | Apligraf | $26 |
| Smith+Nephew | Meals · 2025-12-19 | Oasis | $148 |
| Smith+Nephew | Meals · 2025-11-13 | Grafix Pl | $46 |
| Smith+Nephew | Meals · 2025-11-12 | Grafix Pl | $51 |
| Smith+Nephew | Meals · 2025-10-31 | Grafix Pl | $46 |
| Orthofix Medical | Meals · 2025-10-17 | Physio-Stim | $11 |
| Smith+Nephew | Meals · 2025-09-17 | Grafix Pl | $44 |
| Smith+Nephew | Meals · 2025-09-10 | Grafix Pl | $50 |
| Smith+Nephew | Meals · 2025-08-12 | Grafix Pl | $43 |
| Smith+Nephew | Meals · 2025-08-07 | Collagenase Santyl | $5 |
| Smith+Nephew | Meals · 2025-07-02 | Collagenase Santyl | $18 |
| Paratek Pharmaceuticals | Meals · 2025-06-30 | Nuzyra | $17 |
| Smith+Nephew | Meals · 2025-06-10 | Collagenase Santyl | $11 |
| Smith+Nephew | Meals · 2025-06-07 | Grafix | $44 |
| AngioDynamics | Meals · 2025-06-04 | Auryon Laser System 100-120 Vac | $125 |
| Smith+Nephew | Meals · 2025-05-29 | Collagenase Santyl | $19 |
| Abbvie | Meals · 2025-05-22 | Teflaro | $14 |
| Paratek Pharmaceuticals | Meals · 2025-05-16 | Nuzyra | $17 |
| Smith+Nephew | Meals · 2025-05-15 | Renasys Touch | $15 |
| Paratek Pharmaceuticals | Meals · 2025-04-18 | Nuzyra | $25 |
| Innovation Technologies | Meals · 2025-04-15 | Irrisept | $14 |
| Smith+Nephew | Meals · 2025-04-01 | Collagenase Santyl | $4 |
| Smith+Nephew | Meals · 2025-03-31 | Collagenase Santyl | $5 |
| Smith+Nephew | Meals · 2025-03-31 | Grafix Pl | $43 |
| Paratek Pharmaceuticals | Meals · 2025-03-14 | Nuzyra | $18 |
| Smith+Nephew | Meals · 2025-03-13 | Grafix Pl | $42 |
| Abbvie | Meals · 2025-02-19 | Teflaro | $16 |
| Smith+Nephew | Meals · 2025-02-19 | Collagenase Santyl | $3 |
| Smith+Nephew | Meals · 2025-02-19 | Collagenase Santyl | $5 |
| Medtronic | Meals · 2025-02-05 | Inceptiv | $157 |
| Smith+Nephew | Meals · 2025-01-29 | Collagenase Santyl | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,492
| Smith+Nephew | Grafix Pl | $1,045 | 22 payments
|
| Stryker | Actishield | $162 | 2 payments
|
| Organogenesis | None | $117 | 2 payments
|
| Urgo Medical North America | Urgoclean Ag | $79 | 2 payments
|
| Abbvie | Teflaro | $47 | 2 payments
|
| ConvaTec | Aquacel Ag+ | $29 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $14 | 1 payment
|
2023: $11,915
| Smith+Nephew | Grafix Pl | $10,535 | 32 payments
|
| Treace Medical Concepts | Lapiplasty System | $705 | 2 payments
|
| Medtronic | Intellis Adaptivestim | $490 | 3 payments
|
| Nevro | Senza | $64 | 3 payments
|
| Organogenesis | Puraply | $62 | 2 payments
|
| Averitas Pharma | Qutenza | $25 | 1 payment
|
| Next Science | Surgx | $19 | 1 payment
|
| Djo | Aircast | $15 | 1 payment
|
2022: $13,969
| Smith+Nephew | Grafix | $13,242 | 33 payments
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $420 | 5 payments
|
| Horizon Therapeutics plc | Krystexxa | $118 | 1 payment
|
| Organogenesis | Puraply | $108 | 1 payment
|
| Kci USA | Activ.A.C. | $33 | 2 payments
|
| Melinta Therapeutics | Kimyrsa | $24 | 1 payment
|
| Abbvie | Dalvance | $24 | 1 payment
|
2021: $2,100
| Smith+Nephew | Grafix Pl | $1,385 | 51 payments
|
| Organogenesis | Puraply | $511 | 5 payments
|
| AngioDynamics | Auryon Laser System 100-120 Vac | $153 | 1 payment
|
| Tissuetech | Neox | $52 | 3 payments
|
2020: $6,829
| Smith+Nephew | Grafix | $6,270 | 91 payments
|
| Organogenesis | Puraply | $339 | 19 payments
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $76 | 1 payment
|
| Zimmer Biomet Holdings | Juggerknot-Foot & Ankle | $40 | 1 payment
|
| PolarityTE | Skinte | $36 | 1 payment
|
| Amniox Medical | Neox | $33 | 3 payments
|
| ConvaTec | Aquacel | $21 | 1 payment
|
| Tactile Systems Technology | Flexitouch | $15 | 1 payment
|
2019: $31,202
| Osiris Therapeutics | Grafixpl | $15,143 | 96 payments
|
| Smith+Nephew | Grafixpl | $14,666 | 145 payments
|
| Organogenesis | Apligraf | $678 | 54 payments
|
| Integra LifeSciences | Omnigraft | $157 | 5 payments
|
| Stryker | None | $144 | 1 payment
|
| Kci USA | Snap | $125 | 1 payment
|
| Wright Medical Technology | Augment | $120 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $110 | 11 payments
|
| Checkpoint Surgical | Checkpoint Stimulators | $23 | 1 payment
|
| Melinta Therapeutics | Baxdela | $23 | 1 payment
|
| Tetraphase Pharmaceuticals | Xerava | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| RedDress LTD · A Multi-Center, Prospective, Randomized, Controlled, Trial, Comparing the Safety and Efficacy of Actigraft Pro To Standard of Care in Patients With Chronic Neuropathic Diabetic Foot Ulcers · 2023 | Their institution | $34,382 |
| RedDress LTD · A Multi-Center, Prospective, Randomized, Controlled, Trial, Comparing the Safety and Efficacy of Actigraft Pro To Standard of Care in Patients With Chronic Neuropathic Diabetic Foot Ulcers · 2022 | Their institution | $15,042 |
| Globus Medical, Inc. · Aminos Rt · 2021 | Their institution | $6,289 |
| Globus Medical, Inc. · Aminos Rt · 2020 | Their institution | $4,600 |
| AXOGEN · Study of Axoguard Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (Repose) · 2022 | Their institution | $3,189 |
| Osiris Therapeutics Inc. · Grafixpl Prime Evaluation · 2019 | This clinician | $2,250 |
| AXOGEN · Study of Axoguard Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (Repose) · 2021 | Their institution | $1,250 |
| Globus Medical, Inc. · Aminos Rt · 2022 | Their institution | $295 |
| AXOGEN · Study of Axoguard Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain (Repose) · 2023 | Their institution | $295 |
| RedDress LTD · A Multi-Center, Prospective, Randomized, Controlled, Trial, Comparing the Safety and Efficacy of Actigraft Pro To Standard of Care in Patients With Chronic Neuropathic Diabetic Foot Ulcers · 2021 | Their institution | $58 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033120787
- Licence
- CA E45820
- Trained
- California School of Podiatric Medicine, 2002 · 24 years ago
- Group
- Gabriel J Halperin D P M Inc · White Memorial Medical Center
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 000E45820
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 3616 E 1st St, Los Angeles, CA, 90063
- NPI first listed
- 2006-08-10
- NPI last updated
- 2026-07-20
- NPI record certified
- 2026-07-20
This is when the NPI record was last certified, not a medical board exam.